uniQure may seek approval in the UK first while in talks with the FDA about its request for a larger, sham-controlled trial of the one-time, invasive gene therapy AMT-130.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/huntington-therapy-faces-regulatory-roller-coaster-2026a1000k0l?src=rss
Author :
Publish date : 2026-06-26 16:40:00
Copyright for syndicated content belongs to the linked Source.
